LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC, a shareholder rights firm announces a class action lawsuit against NantHealth, Inc. (“NantHealth” or the “Company”) (Nasdaq: NH). Investors who purchased or otherwise acquired NantHealth shares between February 19, 2013 and March 1, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the May 2, 2017 lead plaintiff deadline.
To participate in this class action lawsuit, call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at email@example.com.
No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
STAT, an organization providing medical industry reporting, published an article stating that NantHealth founder, Patrick Soon-Shiong, had rendered $12 million to the University of Utah through tax-exempt entities that he controlled. The contract required the University to expend most of these funds into NantHealth. STAT alleges the plan allowed the Company to artificially inflate the number of test orders it reported to shareholders.
When this news was revealed to the investing public, the value of NantHealth dropped, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.